Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

100%

4 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4
4(100.0%)
4Total
Phase 4(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00484471Phase 4Completed

ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness

Role: lead

NCT00272467Phase 4Completed

Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy

Role: lead

NCT02069977Phase 4Unknown

Study to Evaluate the Efficacy and Safety of Aripiprazole

Role: collaborator

NCT00130039Phase 4Completed

Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II

Role: collaborator

All 4 trials loaded